Continuation of dabigatran therapy in "real-world" practice in Hong Kong.

Continuation of dabigatran therapy in "real-world" practice in Hong Kong.

BACKGROUND: Dabigatran, an oral direct thrombin inhibitor, possesses several advantages over warfarin that can in principle simplify the management of stroke prevention in atrial fibrillation (AF). Nonetheless it remains unclear whether these advantages can translate to clinical practice and encoura...

Full description

Bibliographic Details
Main Authors: Mei Han Ho, Chi Wai Ho, Emmanuel Cheung, Pak Hei Chan, Jo Jo Hai, Koon Ho Chan, Esther W Chan, Gilberto Ka Kit Leung, Hung Fat Tse, Chung Wah Siu
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4118845?pdf=render

Internet

http://europepmc.org/articles/PMC4118845?pdf=render

Similar Items